These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 14566337)
1. Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain. Lizée G; Basha G; Tiong J; Julien JP; Tian M; Biron KE; Jefferies WA Nat Immunol; 2003 Nov; 4(11):1065-73. PubMed ID: 14566337 [TBL] [Abstract][Full Text] [Related]
2. Follicular and marginal zone B cells fail to cross-present MHC class I-restricted epitopes derived from viral particles. Keller SA; von Allmen CE; Hinton HJ; Bauer M; Muntwiler S; Dietmeier K; Saudan P; Bachmann MF J Immunol; 2009 May; 182(10):6261-6. PubMed ID: 19414779 [TBL] [Abstract][Full Text] [Related]
3. CTL induction by cross-priming is restricted to immunodominant epitopes. Pavelic V; Matter MS; Mumprecht S; Breyer I; Ochsenbein AF Eur J Immunol; 2009 Mar; 39(3):704-16. PubMed ID: 19189311 [TBL] [Abstract][Full Text] [Related]
4. Dendritic cells use endocytic pathway for cross-priming class Ib MHC-restricted CD8alphaalpha+TCRalphabeta+ T cells with regulatory properties. Smith TR; Tang X; Maricic I; Garcia Z; Fanchiang S; Kumar V J Immunol; 2009 Jun; 182(11):6959-68. PubMed ID: 19454693 [TBL] [Abstract][Full Text] [Related]
5. IRAP identifies an endosomal compartment required for MHC class I cross-presentation. Saveanu L; Carroll O; Weimershaus M; Guermonprez P; Firat E; Lindo V; Greer F; Davoust J; Kratzer R; Keller SR; Niedermann G; van Endert P Science; 2009 Jul; 325(5937):213-7. PubMed ID: 19498108 [TBL] [Abstract][Full Text] [Related]
6. Cross-presentation: underlying mechanisms and role in immune surveillance. Rock KL; Shen L Immunol Rev; 2005 Oct; 207():166-83. PubMed ID: 16181335 [TBL] [Abstract][Full Text] [Related]
7. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation. Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504 [TBL] [Abstract][Full Text] [Related]
8. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Heath WR; Belz GT; Behrens GM; Smith CM; Forehan SP; Parish IA; Davey GM; Wilson NS; Carbone FR; Villadangos JA Immunol Rev; 2004 Jun; 199():9-26. PubMed ID: 15233723 [TBL] [Abstract][Full Text] [Related]
9. A novel pathway of antigen presentation by dendritic and endothelial cells: Implications for allorecognition and infectious diseases. Smyth LA; Herrera OB; Golshayan D; Lombardi G; Lechler RI Transplantation; 2006 Jul; 82(1 Suppl):S15-8. PubMed ID: 16829787 [TBL] [Abstract][Full Text] [Related]
10. The delivery of an antigen from the endocytic compartment into the cytosol for cross-presentation is restricted to early immature dendritic cells. Hotta C; Fujimaki H; Yoshinari M; Nakazawa M; Minami M Immunology; 2006 Jan; 117(1):97-107. PubMed ID: 16423045 [TBL] [Abstract][Full Text] [Related]
11. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Allan RS; Waithman J; Bedoui S; Jones CM; Villadangos JA; Zhan Y; Lew AM; Shortman K; Heath WR; Carbone FR Immunity; 2006 Jul; 25(1):153-62. PubMed ID: 16860764 [TBL] [Abstract][Full Text] [Related]
12. Natural killer cells license dendritic cell cross-presentation of B lymphoma cell--associated antigens. Dao T; Gomez-Nunez M; Antczak C; Kappel B; Jaggi JS; Korontsvit T; Zakhaleva V; Scheinberg DA Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8763-72. PubMed ID: 16361564 [TBL] [Abstract][Full Text] [Related]
13. Efficiency of peptide presentation by dendritic cells compared with other cell types: implications for cross-priming. Zehn D; Cohen CJ; Reiter Y; Walden P Int Immunol; 2006 Dec; 18(12):1647-54. PubMed ID: 17035346 [TBL] [Abstract][Full Text] [Related]
14. Macrophage-colony stimulating factor enhances MHC-restricted presentation of exogenous antigen in dendritic cells. Han S; Song Y; Lee YH; Lee YR; Lee CK; Cho K; Kim K Cytokine; 2005 Dec; 32(5):187-93. PubMed ID: 16303313 [TBL] [Abstract][Full Text] [Related]
15. Regulation of antigen presentation and cross-presentation in the dendritic cell network: facts, hypothesis, and immunological implications. Wilson NS; Villadangos JA Adv Immunol; 2005; 86():241-305. PubMed ID: 15705424 [TBL] [Abstract][Full Text] [Related]
16. The cross-priming pathway: a portrait of an intricate immune system. Basta S; Alatery A Scand J Immunol; 2007 Apr; 65(4):311-9. PubMed ID: 17386021 [TBL] [Abstract][Full Text] [Related]
17. On cross-priming of MHC class I-specific CTL: rule or exception? Zinkernagel RM Eur J Immunol; 2002 Sep; 32(9):2385-92. PubMed ID: 12207322 [No Abstract] [Full Text] [Related]